CRSP
Crispr Therapeutics Ag
$49.99
Tue, Nov 3, 2026 close (weekly items: Fri, Oct 30)
ARKK holding · entry card
| Buy zone (breakout retest) | — | — | no confirmed breakout, so no retest zone |
| Profit-Taking Zone | $52.48–52.84 | +5.0% to +5.7% | 40-wk SMA, wk low ’25-08-08, 200-day SMA |
| Trading stop · daily close | below $48.02 | -3.9% | trading downgrade |
| Trend stop · Friday close | below $46.07 | -7.8% | trend downgrade one state |
| Breakout Buy Level | close above $52.10 | +4.2% | top of R1 (wk low ’25-09-05, wk low 09-18) |
APPENDIX · CRSP · TECHNICAL TRADING SCORECARD
Scores · Trend 3.3
| RS vs S&P (20) + sector (10) | 2.0 + 0.0 = 2.0 / 30 |
| Structure (6 checks) | 0 / 30 |
| Score = (RS + structure) × 100/60 | 3.3 / 100 |
| Raw state (Up ≥ 60 · Down < 45) | Down |
| Confirmation (2 consecutive Fridays) | confirmed Down |
| Trend (confirmed) | Down |
✖ Fri close above 40-wk SMA 0/6 · ✖ 40-wk SMA rising (4 wks) 0/4 · ✖ No lower high vs cycle high 0/5 · ✖ Fri close above 20-wk SMA 0/5 · ✖ Fri close above 200-wk (4-yr) SMA 0/5 · ✖ 4-mo SMA > 13-mo SMA (completed months, to Sep) 0/5
Weekly raw states: 09-25 Down → 10-02 Up → 10-09 Down → 10-16 Down → 10-23 Down → 10-30 Down. Coppock, band position, breadth and modifiers no longer enter the Trend score (Coppock chart below is reference only). |
Scores · Trading 28.2
| RS (S&P 20 + sector 10) | 8.0 + 0.0 / 30 |
| Structure | 5 / 25 |
| Coppock (daily) — BOUNCE tag — oversold & turning up inside a down structure (no boost) | 2.5 / 25 |
| Band position | 12.7 / 20 |
| Raw | 28.2 (Established Down) |
| Modifiers (10-yr > 5% rising −3, seasonal −2) | +0 |
| Final | 28.2 Established Down |
| ✖ Close above 50-day SMA 0/5 · ✖ 50-day SMA rising (10 d) 0/3 · ✖ Close above 100-day SMA 0/4 · ✖ Close above 200-day SMA 0/5 · ✖ 200-day SMA rising (20 d) 0/3 · ✔ No daily lower high (last two swing highs) 5/5 |
Relative state (weekly RS vs 16-wk SMA + 2-wk slope; daily RS vs 15-d SMA + 3-d slope; Neutral ±0.25%; phase price = next Fri / next close, benchmark flat)
| Horizon · benchmark | State | RS vs SMA | RS chg | Phase-transition price (CRSP close needed) |
|---|
| Trend · S&P | 5 Established Down (+) → | -1.50% | +5.50% | Est. Up ≥ 52.59 (+5.2%) · Est. Down < 50.53 |
| Trend · XLV | 5 Established Down (−) → | -10.44% | -0.20% | Est. Up ≥ 64.74 (+29.5%) · Early Up ≥ 57.75 · Est. Down < 57.44 |
| Trading · S&P | 3 Neutral (−) ↓ | -0.09% | -6.03% | Est. Up ≥ 50.23 (+0.5%) · Est. Down < 47.64 |
| Trading · XLV | 5 Established Down (−) → | -3.69% | -7.86% | Est. Up ≥ 62.80 (+25.6%) · Early Up ≥ 51.96 · Est. Down < 51.69 |
Full bands (cluster rule: 2 or more tools within 3%; Δ vs 49.99)
| Band | Range | Distance | Tools in the cluster |
|---|
| R3 | 55.50–56.16 | +11.0% to +12.3% | wk high 2024-12-06 55.50 · wk high ’25-02-21 55.88 · wk high 05-15 56.16 |
| R2 | 52.48–52.84 | +5.0% to +5.7% | 40-wk SMA 52.48 · wk low ’25-08-08 52.50 · 200-day SMA 52.84 |
| R1 | 50.83–52.10 | +1.7% to +4.2% | wk low ’25-09-05 50.83 · wk low 09-18 51.33 · wk low 08-21 51.80 · wk low 01-02 52.10 |
| S1 | 48.02–49.28 | -1.4% to -3.9% | wk high 2024-10-18 49.28 · wk low 06-12 49.02 · wk low 04-24 48.77 · wk low ’25-11-21 48.02 |
| S2 | 46.07–47.36 | -5.3% to -7.8% | wk low 10-23 47.36 · wk low 05-22 46.92 · wk high ’25-03-14 46.07 |
| S3 | 45.44–45.89 | -8.2% to -9.1% | wk low 07-31 45.89 · wk high ’25-01-24 45.77 · wk low 02-06 45.53 · wk low 2024-11-22 45.51 · wk low 2024-10-25 45.44 |
| ATH | 220.20 | +340.5% | all-time high; Profit-Taking fallback when no 2-tool band sits above the Breakout (extensions no longer used) |
Coppock, breadth and RS (reference only; not in the Trend score)
Stops & phase transitions
- Tier 1 (trading stop): daily close < 48.02 (-3.9%): trading downgrades one state, re-anchor to S2 46.07–47.36.
- Tier 2 (trend stop = Trend Breakdown / invalidation): Friday close < 46.07 (-7.8%): trend downgrades one state, re-anchor to S3 45.44–45.89.
- Trend vs S&P: Est. Up ≥ 52.59 (+5.2%) · above its 16-wk avg ≥ 52.59 · Est. Down < 50.53 (+1.1%) (next Friday, benchmark flat).
- Trading vs S&P: Est. Up ≥ 50.23 · Est. Down < 47.64.
Sluymer context
- Not named in the 15 reports reviewed (Aug 18 – Oct 13, 2026).
Notes & caveats
ARK Innovation ETF (ARKK) holding, entry card (treated like the US Watchlist). Holdings: issuer file as of 2026-11-03 (https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_INNOVATION_ETF_ARKK_HOLDINGS.csv (official ARK daily holdings CSV, date column 11/03/2026)); ETF weight 4.48%. Benchmarks: S&P 500 (20 pts) and XLV (10 pts). Trading items and bands use the Tue, Nov 3, 2026 close; trend uses the Fri, Oct 30 week. Entry levels: Buy Zone = breakout retest zone (BUY names only: from the broken level down to the floor of the resistance band it came from, or level −2%, whichever is tighter; a weekly close below = failed breakout); Breakout Buy Level = top of R1; Trend Breakdown (invalidation) = S2 floor on a Friday close; Profit-Taking = next resistance band above the breakout. Verdict: AVOID = Trend Down (confirmed on two Fridays) or Friday close below a falling 40-wk SMA; BUY = a weekly close above a Breakout Buy Level fixed from the prior week's data with ≥2 tools within 3% (most recent such breakout in the last 4 weeks), every Friday close since and the latest close still at or above it, and Trend not Down; WAIT = otherwise. Buy Zone is reference only. Coppock = 10-bar WMA of ROC(14)+ROC(11), standard settings used as a placeholder because his are unpublished; DAS is omitted. Zone = sign + 3-yr percentile; direction = 2 bars. SMAs are simple; swings are 5-bar extremes; the channel is a 2-yr log regression ±2σ. The breadth proxy is the % of 500 current S&P 500 members with a rising weekly Coppock; it has survivorship bias, is a regime input only, and no other stock was scored. Weights are our choices (playbook §10); the state rule matched 86% / 83% of his sector states in-sample. Data: Yahoo Finance (unadjusted); weight from the Portfolio Dashboard (PIM 11/2 EOD, read-only).
